CNS Flashcards
what is the first line treatment for focal seizures
carbamazepine OR lamotrigine
what is the second line treatment for focal seizures
oxcarbamazepine, Levetiracetam or sodium valproate
MHRA warnings for antiepileptic drugs
- risk of suicidal thoughts and behaviour
- seek advice if change in mood or thoughts
- would need to stop or switch AED - switching between brands = ADR/ loss of seizure control
- dependent on category if brands can be switched
what are the categories and drugs for antiepileptic drugs
category 1: carbamazepine, phenobarbital, phenytoin, primidone (CPPP)
MAINTAIN ON BRAND
category 2: clobazam, clonazepam, lamotrigine, oxcarbamazepine, topiramate, sodium valproate
- use clinical judgement for brand maintenance
category 3: gabapentin, ethosuximide, lacosamide, levetiracetam, pregabalin, vigabatrin
- dont need to maintain on specific brand
What are the 1st and 2nd line treatments for different types of generalised seizures
tonic-clonic: 1st line- sodium valproate, 2nd line: lamotrigine
absence: 1st line- ethosuximide/ sodium valproate, 2nd line: lamotrigine
myoclonic: 1st line- sodium valproate, 2nd line: topiramate/ levetiracetam
atonic: 1st line- sodium valproate, 2nd line: lamotrigine
clonic: 1st line- sodium valproate, 2nd line: lamotrigine
treatment of status epilepticus in hospital and community
hospital
seizures lasting longer than 5 minutes: IV lorazepam or IV diazepam (risk of thrombophelbitis) -> can be repeated after 10 minutes if persists
seizure continuing for more than 25 minutes: IV phenytoin, fosphenytoin or phenobarbital
seizure continuing for more than 45 minutes: thiopental, midazolam or propofol
Community/ resus not available
buccal midazolam OR rectal diazepam
add on drugs:
pyridoxine if pyridoxine deficiency
thiamine if alcohol abuse
which AED can cause steven johnson syndrome
lamotrigine
what AED can cause hypersensitivity syndrome
carbamazepine, phenytoin, phenobarbital, primidone, lamtrogine (CPPPL - category 1 plus lamtorigine)
what AED causes blood dyscrasias
C.VET.PLS
carbamazepine, vigabatrin, ethosuximide, topiramate, phenytoin, lamotrigine, zonisamide
what AED causes eye disorders
vigabatrin (reduced visual field)
topiramate (secondary glaucoma)
signs of phenytoin toxicity and the therapeutic range
therapeutic range: 10-20mg/L
signs of toxicity: slurred speech, nysatgmus, ataxia, confusion, hyperglycaemia, double/ blurred vision
signs of carbamazepine toxicity and therapeutic range
therapeutic range: 4-12mg/l
signs: hyponatraemia, ataxia, nystagmus, drowsiness, blurred vision, arrhythmia, GI disturbance
what AED have high risk in pregnancy and what should be given to reduce risks
highest risk: valproate
high risk: carbamazepine, phenytoin, phenobarbital, primidone, lamotrigine
topiramate in 1st trimester can cause cleft palate
reduce risk:
folic acid 5mg in 1st trimester
vitamin K injection in newborn
which AED are CYP inducers and inhibitors and what do each interact with
CYP inducers: carbamazepine, phenytoin, phenobarbital
- interacts with warfarin, HRT, hypothyroid drugs (lithyronine and levothyroxine) = decreases the concentration
CYP inhibitors: sodium valproate
- interacts with other AED = increases the concentration
which AED are CYP inducers and inhibitors and what do each interact with
CYP inducers: carbamazepine, phenytoin, phenobarbital
- interacts with warfarin, HRT, hypothyroid drugs (lithyronine and levothyroxine) = decreases the concentration
CYP inhibitors: sodium valproate
- interacts with other AED = increases the concentration
what drugs lower the seizure threshold
quinolones, tramadol, theophylline
hepatotoxic drugs that interact with carbamazpine, phenytoin and sodium valproate
amiodarone, itraconazole, macrolides, alcohol
interactions of phenytoin
- antifolates (trimethoprim, MTX)
- phenytoin concentration decreased by enzyme inducers
- phenytoin concentration increased by enzyme inhibitors
therapeutic range for lithium
normal: 0.4-1mmol/l
acute episode: 0.8-1mmol/l
what is the management for dementia
mild- moderate: acetylcholinesterase inhibitors
donepezil
galantamine
rivastigmine
moderate- severe: NMDA antagonist
memantine
aggression:
benzodiazepine/ antipsychotics
what is the MHRA alert for antipsychotics in elderly patients with dementia
risk of stroke and death- review every 6 weeks
what are the side effects of acetylcholinesterase inhibitors donepezil, galantamine and rivastigmine
donepezil: neuroleptic syndrome
rivastigmine: GI side effects- reduced with use of patch
galantamine: steven johnson syndrome - stop as soon as rash seen
what are the side effects of increased acetylcholine
diarrhoea urinary incontinence muscle weakness bradycardia bronchospasms emesis lacrimation (tears) saliva increased
what are the treatment pathways for parkinsons disease
motor symptoms which affect quality of life:
levodopa + benserazide/ carbidopa
motor symptoms which do NOT affect quality of life:
levodopa OR
non-ergot derived dopamine agonists OR
MAOB inhibitors
side effects of levodopa and how these would be managed
impulse disorders -> reduce dose gradually/ withdraw until subsides
sudden onset of sleep -> modafinil
red urine - normal
end of dose deterioration -> Switch to modified release preparations
examples of ergot derived and non-ergot derived dopamine agonists and side effects of these classes
NON-ERGOT DERIVED:
pramipexole, ropinorole, rotigotine
side effects: impulse disorder, sudden sleep, hypotension
ERGOT DERIVED: cabergoline, bromocriptine side effects: fibrotic reactions pulmonary: SOB, chest pain cough pericardial: chest pain,